Changes of Platelet and Blood Coagulating Function During Endovascular Graft Exclusion

徐美英,张富军,包俊敏,朱文忠,赵志青,王利丽,景在平
DOI: https://doi.org/10.3321/j.issn:0258-879x.2002.08.013
2002-01-01
Abstract:Objective:To study the changes of platelet and blood coagulating function during endovascular graft exclusion(EVGE), providing reference for reasonable use of heparin and platelet. Methods:Using sonoclot analysis (SCT), 20 patients accepted EVGE were measured for ACT, clot rate, platelet function and hematocrit (HCT) and platelet count (PLT) after anesthesia induction(T 1), heparination(0.3 0.5 mg/kg)(T 2) and EVGE(T 3), respectively. The reasons for variability were analyzed. Results:ACT, clot rate and blood platelet function were normal at T 1. At T 2 ACT was prolonged [(289± 61.1) s,] clot rate and platelet function were decreased ( P 0.01). At T 3 HCT and PLT were decreased [from 0.41±0.05 to 0.30± 0.03 and from (183±50.8)×10 9/L to (95.0±28.0)×10 9/L]. At T 3, there was no significant difference of ACT, clot rate and platelet function compared with those at T 1. Conclusion:In patients received EVGE, ACT, coagulation and platelet function are normal after anesthesia. Heparination (0.3 0.5 mg/kg) prevents the occurrence of thombosis without increasing hemorrhage. HCT and PLT decrease after endovascular operation, but coagulation and platelet function is recovered. SCT can guide anticoagulation therapy in EVGE reasonably.
What problem does this paper attempt to address?